Dry Fasting — The Record

Pathway atlas · node 9 of 41

NF-κB

What fasting does to this node, by modality, by system and by grade. Disconfirming evidence is reported first.

Founder's components: NFKB1/2, RELA/B, REL, IKBKB, NFKBIA, TNFAIP3. Second most important node in this slice. The literature is large, split, and confounded by weight loss. It is also almost entirely measured at the wrong layer.

THE LAYER PROBLEM, STATED FIRST

Every human fasting row on this node measures NF-κB OUTPUT (circulating IL-6, TNF-alpha, IL-1beta, CRP), not NF-κB. No human fasting study located measured NFKB1, NFKB2, RELA, RELB, REL, IKBKB, NFKBIA or TNFAIP3 protein, nuclear translocation, or IκB degradation. The only evidence touching an actual component is Chung et al. 2001, a review of calorie restriction in rodents reporting that NF-κB activation was suppressed by preventing IκBα and IκBβ dissociation, with no numbers retrieved and the species not stated in the abstract. A cytokine panel is not a measurement of this node.

DRY status

DRY: PRESENT, and the two dry-fast studies point in OPPOSITE directions.

The conflict is reported unresolved. A 30-day intermittent dry fast with nightly rehydration lowered multiple cytokines; a 5-day absolute dry fast with no rehydration raised CRP. The modalities differ in absoluteness, duration and rehydration, and no retrieved source reconciles them. Neither side is selected. Queries run for DRY on this node: the four DRY queries under node 1, plus "Ramadan fasting CRP IL-6 TNF-alpha meta-analysis inflammatory markers", "intermittent fasting NF-kB p65 human PBMC measured protein expression trial" (budget-stopped), "caloric restriction NF-kB signaling aging rodent p65 nuclear translocation reduced".

Disconfirming, nulls and contradictions first

Graded rows

#ModalitySystemTierGradeFindingSource
9.1TRE and IF-ADFHuman, 11 randomized trialsH1B+IL-6: 0 of 5 decreased. TNF-alpha: 0 of 4 decreased. CRP: 3 of 8 decreased, all three IF-ADF. OUTPUT LAYER.Mulas et al. 2023, Front Nutr 10:1146924, DOI 10.3389/fnut.2023.1146924
9.2TRE vs CR, 12 monthsHuman, obesity, randomized, secondary analysisH1B+No significant change in TNF-alpha, IL-6 or CRP within or between groups at 12 months, despite 4 to 5 percent weight loss in both arms. CRP related to body weight, visceral fat and insulin resistance; IL-6 and TNF-alpha related to no metabolic marker.Lin et al. 2025, Nutrients 17(7):1130, PMID 40218888, DOI 10.3390/nu17071130
9.3Mixed IF (pooled)Human, 21 studies, 839 participantsH1B+TNF-alpha SMD -0.31 p=0.009; CRP SMD -0.19 p=0.04; leptin SMD -0.57 p=0.005. IL-6 and adiponectin NOT significant. TRF largest TNF-alpha reduction -0.39 p=0.001; 5:2 ranked highest for CRP. CIs not reported in the retrieved abstract.Khalafi et al. 2025, Nutrients 17(15):2388, PMID 40805975, DOI 10.3390/nu17152388
9.4Mixed IF (pooled)Human, 8 RCTs, 573 participantsH1B+IL-6 reduced, WMD -0.58, 95% CI -1.08 to -0.08, p = 0.022. CONTRADICTS ROW 9.3 ON IL-6. Also FBS -3.34 (-6.24 to -0.45) p=0.024; HbA1c -0.08 (-0.13 to -0.02) p=0.005; HOMA-IR -0.60 (-0.91 to -0.28) p<0.001; LDL-c -6.42 (-12.26 to -0.58) p=0.031.Lü et al. 2025, J Health Popul Nutr 44(1):293, PMID 40826125, DOI 10.1186/s41043-025-01039-2
9.5DRY (30 d dawn-to-dusk)Human, increased BMI, single-arm observationalH3CIL-1beta down at week 4 (p=0.045), persisting after (p=0.024); TNF-alpha down (p=0.046); IL-15 (p=0.014), IL-1RA (p=0.041), MDC (p=0.013), CXCL9 (p=0.027), FGF2 (p=0.010), IL-12p40 (p=0.038), IL-22 (p=0.025) down. Weight, BMI, waist, hip and resting heart rate down. Cytokine changes correlated with waist change. n NOT STATED in the retrieved record. OUTPUT LAYER.Al lami et al. 2024, Metabolism Open 21:100274, PMID 38455231, DOI 10.1016/j.metop.2024.100274
9.6DRY (5 d absolute)Human, n=10H3CCRP INCREASED. With increases in ADH, ACTH, cortisol (about +495 percent), urine osmolality, renin, angiotensin II, aldosterone, total antioxidant capacity, uric acid, albumin, erythrocytes, hematocrit, noradrenaline and dopamine excretion; decreases in body weight, waist, erythropoietin, adrenaline excretion and Na+ excretion. Vitamin C half-life about 4.8 days. CONTRADICTS ROW 9.5.Papagiannopoulos-Vatopaidinos et al. 2020, Complement Med Res 27(4):242-251, PMID 31958788, DOI 10.1159/000505201
9.7RAMADAN (1 month)Human, n=40 fasting vs n=28 matched controlsH2BIL-6 and CRP significantly LOWER during Ramadan than at baseline, p < 0.001 each, with no change in controls. Homocysteine also lower. Total cholesterol, triglycerides and LDL unchanged. Absolute values not retrieved.Aksungar et al. 2007, Ann Nutr Metab 51(1):88-95, PMID 17374948, DOI 10.1159/000100954
9.8RAMADAN (1 month, summer, Germany)Human, n=50 healthy young males, prospective controlledH2CIL-1beta INCREASED significantly from T2 to T4 and T3 to T4 in the fasting group. NO significant difference between fasting and non-fasting groups at T1 or T3 for any cytokine measured. TNF-alpha correlated with body weight, skeletal muscle mass and fat-free mass at T3. Magnitudes and p-values paywalled.Khoshandam Ghashang et al. 2021, J Complement Integr Med 18(2):425-431, DOI 10.1515/jcim-2019-0209
9.9RAMADANHuman, n=68 Saudi adults with diabetes, pre vs duringH3CLower log IL-6 and lower CRP; higher log HDL-C; lower body weight, waist and hip, after adjustment for confounders. No effect sizes or p-values retrieved.Aljahdali et al. 2024, Curr Diabetes Rev 20(9):e080124225329, PMID 38192134, DOI 10.2174/0115733998274064231114075657
9.10PF (36 h)Human PBMC, n=10H3CTNF -1.74, IL1B -2.04, CXCL2 -2.06, CCL3 -2.11, IER3 -1.95, NFKBIZ -1.57 at nominal p<0.05. NFKBIZ is the only NF-κB-family gene in the list. NO GENE SURVIVED FDR < 5 PERCENT by the authors' own statement.Elliott et al. 2014, Genes Nutr 9:432, DOI 10.1007/s12263-014-0432-4
9.11PF (3 d, water allowed)Rat left ventricle, male Wistar, n=5 to 13A1CIL-6 and TNF-alpha protein UNCHANGED. Authors used this null to argue against reduced basal inflammation as an explanation for the HIF-1α fall they measured.Benak et al. 2024, Front Physiol 15:1462014, DOI 10.3389/fphys.2024.1462014
9.12CRSpecies not stated in abstract; MeSH lists miceMCAge-related increases in NF-κB, IL-1beta, IL-6, TNF-alpha, COX-2 and inducible nitric oxide synthase attenuated by calorie restriction; NF-κB activation suppressed by preventing IκBα and IκBβ dissociation. THE ONLY EVIDENCE IN THIS NODE TOUCHING AN ACTUAL NF-κB COMPONENT. Review. No numbers, no IKK or p65 data retrieved. CR IS NOT FASTING AND IS LABELED.Chung et al. 2001, Ann N Y Acad Sci 928(1):327-335, PMID 11795524, DOI 10.1111/j.1749-6632.2001.tb05662.x
9.13KD (mouse) and none (human monocytes)Human monocytes; mouse in vivo disease modelsC1 and A1CBHB suppressed NLRP3 activation by urate crystals, ATP and lipotoxic fatty acids; acetoacetate, butyrate and acetate did not; no effect on NLRC4, AIM2 or caspase-11; mechanism via preventing K+ efflux and reducing ASC oligomerization and speck formation. Reduced IL-1beta and IL-18 in human monocytes; BHB or ketogenic diet reduced caspase-1 activation and IL-1beta in mouse models. NO HUMAN FASTING INTERVENTION. NLRP3 IS NOT AN NF-κB COMPONENT. BHB concentrations not retrieved.Youm et al. 2015, Nat Med 21(3):263-269, PMID 25686106, DOI 10.1038/nm.3804

Open questions


← 8. TGF-β / SMAD All 41 nodes 10. HIF / hypoxia →


dryfasting.com has been published since 2014. This evidence record was compiled on 22 November 2026. Every row names the fasting modality the study actually ran, the system it was measured in and the grade. Where no source carries a DOI or PMID the row says so rather than supplying one. Nothing is sold on this site.